Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CRESTONE, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-09 to 2024-10-11
Current total value of award: $23443941
Description: TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.